| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 85 | 2015 | 2947 | 3.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 43 | 2013 | 2508 | 1.390 |
Why?
|
| Gene Expression Profiling | 48 | 2013 | 5159 | 1.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 43 | 2015 | 8873 | 0.830 |
Why?
|
| RNA, Neoplasm | 15 | 2013 | 771 | 0.800 |
Why?
|
| Gene Expression Regulation, Leukemic | 9 | 2011 | 560 | 0.400 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 23 | 2014 | 3639 | 0.360 |
Why?
|
| Zinc | 2 | 2008 | 188 | 0.330 |
Why?
|
| RNA, Messenger | 22 | 2014 | 6150 | 0.330 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2012 | 1064 | 0.320 |
Why?
|
| Cisplatin | 3 | 2013 | 2432 | 0.280 |
Why?
|
| Oligonucleotide Probes | 3 | 2004 | 130 | 0.280 |
Why?
|
| Base Sequence | 17 | 2014 | 4917 | 0.270 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2005 | 38 | 0.270 |
Why?
|
| Gene Expression Regulation | 12 | 2014 | 4053 | 0.260 |
Why?
|
| Genome, Human | 5 | 2013 | 1869 | 0.260 |
Why?
|
| Repressor Proteins | 5 | 2011 | 1664 | 0.260 |
Why?
|
| Genome | 2 | 2010 | 672 | 0.260 |
Why?
|
| Cell Line, Tumor | 31 | 2013 | 14551 | 0.250 |
Why?
|
| Transcriptome | 5 | 2013 | 1859 | 0.250 |
Why?
|
| Gene Expression | 8 | 2013 | 3570 | 0.240 |
Why?
|
| Up-Regulation | 12 | 2014 | 2450 | 0.230 |
Why?
|
| Ribonuclease III | 5 | 2013 | 182 | 0.230 |
Why?
|
| Apoptosis | 13 | 2014 | 7591 | 0.220 |
Why?
|
| Blotting, Northern | 7 | 2008 | 682 | 0.220 |
Why?
|
| Cell Differentiation | 10 | 2011 | 4078 | 0.220 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 362 | 0.220 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2014 | 56 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2013 | 621 | 0.220 |
Why?
|
| Precancerous Conditions | 2 | 2008 | 1058 | 0.210 |
Why?
|
| Mice | 35 | 2015 | 34495 | 0.210 |
Why?
|
| Esophageal Neoplasms | 5 | 2009 | 3168 | 0.210 |
Why?
|
| Animals | 42 | 2015 | 59536 | 0.210 |
Why?
|
| Adenocarcinoma | 10 | 2013 | 7789 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2010 | 1242 | 0.200 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 2 | 1998 | 17 | 0.200 |
Why?
|
| Genomics | 3 | 2012 | 2738 | 0.200 |
Why?
|
| Paclitaxel | 1 | 2008 | 1996 | 0.200 |
Why?
|
| RNA Processing, Post-Transcriptional | 4 | 2010 | 154 | 0.200 |
Why?
|
| Humans | 100 | 2015 | 261506 | 0.190 |
Why?
|
| Receptor, IGF Type 2 | 2 | 1998 | 14 | 0.190 |
Why?
|
| Cell Line | 12 | 2013 | 5114 | 0.190 |
Why?
|
| Ovarian Neoplasms | 4 | 2008 | 4638 | 0.190 |
Why?
|
| HeLa Cells | 6 | 2015 | 1643 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 3 | 2013 | 651 | 0.180 |
Why?
|
| Myeloid Cells | 3 | 2014 | 269 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 | 2009 | 2390 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2012 | 2027 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 11 | 4 | 2008 | 402 | 0.180 |
Why?
|
| Biomarkers, Tumor | 10 | 2014 | 10331 | 0.180 |
Why?
|
| Cell Survival | 7 | 2013 | 3045 | 0.180 |
Why?
|
| Peptide Hydrolases | 2 | 1998 | 256 | 0.170 |
Why?
|
| Cell Hypoxia | 2 | 2013 | 328 | 0.170 |
Why?
|
| Homeodomain Proteins | 5 | 2011 | 1143 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2013 | 5178 | 0.170 |
Why?
|
| Computational Biology | 6 | 2012 | 1271 | 0.170 |
Why?
|
| Tamoxifen | 2 | 2013 | 876 | 0.170 |
Why?
|
| Lysosomes | 2 | 1998 | 347 | 0.160 |
Why?
|
| Cations | 1 | 1998 | 62 | 0.160 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 6089 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 2 | 2013 | 577 | 0.160 |
Why?
|
| Down-Regulation | 12 | 2011 | 2074 | 0.160 |
Why?
|
| Nuclear Proteins | 7 | 2012 | 3343 | 0.160 |
Why?
|
| Vitamin D | 2 | 2011 | 261 | 0.160 |
Why?
|
| Dendritic Cells | 3 | 2014 | 1085 | 0.160 |
Why?
|
| Cell Cycle | 5 | 2010 | 2084 | 0.150 |
Why?
|
| Thyroid Neoplasms | 4 | 2013 | 1866 | 0.150 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 2045 | 0.150 |
Why?
|
| Antigens, CD34 | 6 | 2010 | 593 | 0.150 |
Why?
|
| Cells, Cultured | 10 | 2015 | 5637 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2008 | 317 | 0.140 |
Why?
|
| ADP-Ribosylation Factors | 2 | 2007 | 32 | 0.140 |
Why?
|
| Gene Silencing | 5 | 2013 | 837 | 0.140 |
Why?
|
| Membrane Proteins | 5 | 2013 | 2819 | 0.140 |
Why?
|
| Epigenesis, Genetic | 4 | 2013 | 1399 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 1 | 1996 | 81 | 0.140 |
Why?
|
| Liver Neoplasms | 6 | 2012 | 4557 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2014 | 2291 | 0.140 |
Why?
|
| Neoplasms | 11 | 2015 | 15193 | 0.130 |
Why?
|
| Mutation | 14 | 2012 | 15179 | 0.130 |
Why?
|
| Leukemia | 3 | 2010 | 1635 | 0.130 |
Why?
|
| Costello Syndrome | 1 | 2015 | 18 | 0.130 |
Why?
|
| Autophagy | 2 | 2013 | 927 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 778 | 0.130 |
Why?
|
| Cyst Fluid | 1 | 2014 | 21 | 0.130 |
Why?
|
| Cluster Analysis | 7 | 2012 | 1053 | 0.120 |
Why?
|
| Chromosome Mapping | 4 | 2007 | 1471 | 0.120 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2014 | 4 | 0.120 |
Why?
|
| DNA | 4 | 2013 | 2693 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2010 | 854 | 0.120 |
Why?
|
| Signal Transduction | 9 | 2014 | 11965 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2015 | 2359 | 0.120 |
Why?
|
| Immune Tolerance | 2 | 2013 | 403 | 0.120 |
Why?
|
| Stomach Neoplasms | 4 | 2012 | 2278 | 0.120 |
Why?
|
| Pancreatic Cyst | 1 | 2014 | 107 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2013 | 244 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 1130 | 0.110 |
Why?
|
| RNA, Untranslated | 3 | 2013 | 237 | 0.110 |
Why?
|
| Sirtuin 3 | 1 | 2013 | 38 | 0.110 |
Why?
|
| Argonaute Proteins | 1 | 2013 | 40 | 0.110 |
Why?
|
| Blotting, Western | 6 | 2010 | 3536 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 6 | 2012 | 3203 | 0.110 |
Why?
|
| Transcription, Genetic | 7 | 2008 | 3154 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2013 | 62 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 162 | 0.110 |
Why?
|
| Breast Neoplasms | 11 | 2013 | 15694 | 0.110 |
Why?
|
| Carcinoma, Papillary | 2 | 2006 | 584 | 0.100 |
Why?
|
| Glioblastoma | 4 | 2013 | 1797 | 0.100 |
Why?
|
| Interleukin-23 | 1 | 2011 | 29 | 0.100 |
Why?
|
| Mutant Proteins | 2 | 2015 | 234 | 0.100 |
Why?
|
| Intestines | 2 | 2014 | 686 | 0.100 |
Why?
|
| Endometrial Neoplasms | 2 | 2012 | 1341 | 0.100 |
Why?
|
| DNA Methylation | 7 | 2012 | 2669 | 0.100 |
Why?
|
| Female | 39 | 2013 | 141928 | 0.100 |
Why?
|
| Oncogenes | 2 | 2012 | 673 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2009 | 542 | 0.100 |
Why?
|
| Carcinoma | 3 | 2007 | 2578 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 6942 | 0.100 |
Why?
|
| Gene Fusion | 1 | 2013 | 209 | 0.100 |
Why?
|
| Cell Proliferation | 7 | 2009 | 7226 | 0.100 |
Why?
|
| Receptors, OSM-LIF | 1 | 2010 | 12 | 0.100 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 39 | 0.100 |
Why?
|
| ras Proteins | 1 | 2015 | 770 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2015 | 1331 | 0.100 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2011 | 113 | 0.090 |
Why?
|
| E2F1 Transcription Factor | 2 | 2010 | 206 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 1081 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 6 | 2013 | 2314 | 0.090 |
Why?
|
| Interleukin-12 | 1 | 2011 | 253 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 677 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 709 | 0.090 |
Why?
|
| Cytidine Deaminase | 1 | 2010 | 83 | 0.090 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2009 | 16 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 534 | 0.090 |
Why?
|
| Metallothionein | 2 | 2008 | 34 | 0.090 |
Why?
|
| Histone Acetyltransferases | 1 | 2011 | 411 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2011 | 6915 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 862 | 0.090 |
Why?
|
| Calgranulin A | 1 | 2008 | 12 | 0.090 |
Why?
|
| Reproducibility of Results | 6 | 2012 | 6009 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 55 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2012 | 2341 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 413 | 0.080 |
Why?
|
| Macrophages | 4 | 2014 | 1304 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 673 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2010 | 292 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 558 | 0.080 |
Why?
|
| Leukemia, Large Granular Lymphocytic | 1 | 2009 | 63 | 0.080 |
Why?
|
| Prostatic Neoplasms | 3 | 2013 | 5767 | 0.080 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2008 | 72 | 0.080 |
Why?
|
| Mitochondria | 2 | 2013 | 1282 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 261 | 0.080 |
Why?
|
| Prognosis | 14 | 2013 | 21713 | 0.080 |
Why?
|
| Rats | 5 | 2008 | 6086 | 0.080 |
Why?
|
| Burkitt Lymphoma | 1 | 2011 | 335 | 0.080 |
Why?
|
| Genes, Neoplasm | 2 | 2009 | 324 | 0.080 |
Why?
|
| E2F7 Transcription Factor | 1 | 2008 | 1 | 0.080 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2008 | 132 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2008 | 4821 | 0.080 |
Why?
|
| Male | 29 | 2013 | 123000 | 0.080 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2009 | 155 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 3 | 2014 | 5061 | 0.080 |
Why?
|
| Cell Movement | 3 | 2012 | 2466 | 0.080 |
Why?
|
| Tumor Escape | 1 | 2010 | 251 | 0.080 |
Why?
|
| Archaea | 1 | 2007 | 18 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2005 | 141 | 0.080 |
Why?
|
| Virus Latency | 1 | 2008 | 78 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 287 | 0.080 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2010 | 291 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 840 | 0.080 |
Why?
|
| Molecular Probe Techniques | 1 | 2008 | 46 | 0.080 |
Why?
|
| Breast Neoplasms, Male | 1 | 2009 | 229 | 0.080 |
Why?
|
| B-Lymphocytes | 3 | 2009 | 1294 | 0.080 |
Why?
|
| Solvents | 1 | 2007 | 66 | 0.080 |
Why?
|
| Cytogenetics | 1 | 2008 | 149 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2009 | 145 | 0.080 |
Why?
|
| Rett Syndrome | 1 | 2010 | 262 | 0.080 |
Why?
|
| Models, Biological | 3 | 2015 | 3254 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2007 | 2232 | 0.080 |
Why?
|
| Microbiota | 1 | 2014 | 547 | 0.080 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 66 | 0.080 |
Why?
|
| Photoreceptor Cells | 1 | 2007 | 75 | 0.070 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2008 | 118 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 205 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2009 | 255 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 2013 | 4849 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2011 | 889 | 0.070 |
Why?
|
| Exome | 1 | 2012 | 1239 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2005 | 479 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2011 | 2488 | 0.070 |
Why?
|
| Multigene Family | 1 | 2008 | 425 | 0.070 |
Why?
|
| Insulinoma | 1 | 2006 | 55 | 0.070 |
Why?
|
| Pancreas | 2 | 2007 | 718 | 0.070 |
Why?
|
| Light | 1 | 2007 | 245 | 0.070 |
Why?
|
| Amino Acid Sequence | 5 | 2007 | 4233 | 0.070 |
Why?
|
| Neoplasm Proteins | 5 | 2009 | 3230 | 0.070 |
Why?
|
| Leukemia, Myeloid | 1 | 2011 | 941 | 0.070 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 229 | 0.070 |
Why?
|
| Pancreatitis, Chronic | 1 | 2007 | 116 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2007 | 392 | 0.070 |
Why?
|
| Zebrafish | 2 | 2007 | 463 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 703 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2009 | 5437 | 0.070 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2006 | 84 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2008 | 387 | 0.070 |
Why?
|
| Keratin-14 | 1 | 2005 | 24 | 0.070 |
Why?
|
| Introns | 2 | 1998 | 432 | 0.070 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2005 | 41 | 0.070 |
Why?
|
| Transfection | 5 | 2009 | 2944 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 1533 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2008 | 1823 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2008 | 652 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 2005 | 74 | 0.070 |
Why?
|
| Megakaryocytes | 1 | 2006 | 104 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2007 | 181 | 0.070 |
Why?
|
| Colonic Neoplasms | 3 | 2009 | 1390 | 0.070 |
Why?
|
| Cyclins | 1 | 2007 | 456 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2005 | 81 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2008 | 306 | 0.070 |
Why?
|
| Antineoplastic Agents | 5 | 2013 | 14289 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 973 | 0.070 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 482 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 566 | 0.070 |
Why?
|
| DNA Primers | 4 | 2010 | 1399 | 0.060 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 1070 | 0.060 |
Why?
|
| Response Elements | 1 | 2005 | 193 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 261 | 0.060 |
Why?
|
| Immunohistochemistry | 5 | 2008 | 7548 | 0.060 |
Why?
|
| Proteins | 1 | 2013 | 1963 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 2216 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2010 | 1016 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2005 | 247 | 0.060 |
Why?
|
| Glioma | 2 | 2013 | 1963 | 0.060 |
Why?
|
| Disease Progression | 6 | 2013 | 6682 | 0.060 |
Why?
|
| HL-60 Cells | 3 | 2011 | 302 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2005 | 358 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 1217 | 0.060 |
Why?
|
| Keratins | 1 | 2005 | 330 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2013 | 2295 | 0.060 |
Why?
|
| Inflammation | 2 | 2011 | 2522 | 0.060 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2004 | 6 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 248 | 0.060 |
Why?
|
| Histones | 1 | 2011 | 1466 | 0.060 |
Why?
|
| Mice, Nude | 5 | 2013 | 4307 | 0.060 |
Why?
|
| Tretinoin | 1 | 2007 | 623 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 4 | 2014 | 3981 | 0.060 |
Why?
|
| DNA Replication | 1 | 2008 | 744 | 0.060 |
Why?
|
| Genetic Markers | 3 | 2008 | 974 | 0.060 |
Why?
|
| Conserved Sequence | 3 | 2013 | 469 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2008 | 966 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2009 | 3101 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 4971 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 4 | 2012 | 2483 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 1443 | 0.060 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2007 | 430 | 0.060 |
Why?
|
| Exons | 2 | 1998 | 1328 | 0.060 |
Why?
|
| In Situ Hybridization | 4 | 2008 | 1037 | 0.060 |
Why?
|
| HCT116 Cells | 3 | 2009 | 348 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2005 | 576 | 0.060 |
Why?
|
| Germ-Line Mutation | 2 | 2005 | 1046 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 984 | 0.060 |
Why?
|
| Lung Neoplasms | 5 | 2010 | 11538 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 1450 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 699 | 0.050 |
Why?
|
| Stem Cells | 2 | 2008 | 1213 | 0.050 |
Why?
|
| Gene Dosage | 3 | 2010 | 829 | 0.050 |
Why?
|
| Middle Aged | 16 | 2013 | 86204 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 634 | 0.050 |
Why?
|
| 3' Untranslated Regions | 2 | 2013 | 343 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 1538 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2011 | 5270 | 0.050 |
Why?
|
| Beclin-1 | 2 | 2013 | 85 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2010 | 2022 | 0.050 |
Why?
|
| Cell Lineage | 3 | 2010 | 668 | 0.050 |
Why?
|
| Aminopeptidases | 2 | 1998 | 34 | 0.050 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 1998 | 23 | 0.050 |
Why?
|
| Serine Proteases | 2 | 1998 | 20 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2008 | 1549 | 0.050 |
Why?
|
| Mice, SCID | 3 | 2012 | 1869 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 3552 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 161 | 0.050 |
Why?
|
| Protein Binding | 3 | 2013 | 3438 | 0.050 |
Why?
|
| Luciferases | 3 | 2007 | 445 | 0.050 |
Why?
|
| Liver | 3 | 2014 | 2961 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 2265 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2014 | 1724 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 1756 | 0.050 |
Why?
|
| Time Factors | 4 | 2009 | 12926 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2008 | 1818 | 0.050 |
Why?
|
| Survival Analysis | 5 | 2013 | 9180 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1664 | 0.050 |
Why?
|
| Fetus | 1 | 2004 | 601 | 0.050 |
Why?
|
| Hydrogels | 1 | 2001 | 123 | 0.050 |
Why?
|
| U937 Cells | 2 | 2011 | 171 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 423 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2010 | 1763 | 0.050 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2011 | 65 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2001 | 227 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 4844 | 0.050 |
Why?
|
| Endopeptidases | 2 | 1998 | 220 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2010 | 5710 | 0.040 |
Why?
|
| Heart Failure | 2 | 2013 | 2516 | 0.040 |
Why?
|
| Aged | 12 | 2013 | 70117 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2013 | 4804 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 2 | 2013 | 279 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1997 | 629 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1493 | 0.040 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2008 | 801 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 4143 | 0.040 |
Why?
|
| Codon, Initiator | 1 | 1998 | 14 | 0.040 |
Why?
|
| Feedback, Physiological | 2 | 2010 | 193 | 0.040 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2008 | 61 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 2138 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2012 | 7222 | 0.040 |
Why?
|
| DNA, Neoplasm | 3 | 2008 | 1910 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2012 | 310 | 0.040 |
Why?
|
| Aged, 80 and over | 7 | 2012 | 29902 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2013 | 5395 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2011 | 2979 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 3869 | 0.040 |
Why?
|
| Cell Division | 3 | 2008 | 2489 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2010 | 518 | 0.040 |
Why?
|
| K562 Cells | 2 | 2008 | 338 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2009 | 528 | 0.040 |
Why?
|
| Algorithms | 1 | 2008 | 3890 | 0.040 |
Why?
|
| Adult | 9 | 2012 | 77950 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2009 | 2283 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 598 | 0.040 |
Why?
|
| Plectin | 1 | 1996 | 4 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2013 | 612 | 0.040 |
Why?
|
| Chromosome Deletion | 3 | 2006 | 1005 | 0.040 |
Why?
|
| Biological Transport | 1 | 1998 | 597 | 0.040 |
Why?
|
| Metaphase | 1 | 1996 | 107 | 0.040 |
Why?
|
| Brain | 2 | 2010 | 4113 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2011 | 560 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 1121 | 0.030 |
Why?
|
| Fetal Blood | 2 | 2010 | 482 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 2 | 2005 | 87 | 0.030 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2005 | 102 | 0.030 |
Why?
|
| Peptides | 1 | 2001 | 1479 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2011 | 1620 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2007 | 798 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2014 | 30 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 997 | 0.030 |
Why?
|
| Reference Values | 2 | 2007 | 1099 | 0.030 |
Why?
|
| Thyroid Gland | 2 | 2007 | 355 | 0.030 |
Why?
|
| Phenotype | 3 | 2012 | 6295 | 0.030 |
Why?
|
| Base Pairing | 1 | 2014 | 68 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2008 | 6207 | 0.030 |
Why?
|
| Methylation | 2 | 2011 | 597 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 3022 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 889 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1993 | 63 | 0.030 |
Why?
|
| Lung | 2 | 2010 | 3151 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2013 | 111 | 0.030 |
Why?
|
| Testosterone Congeners | 1 | 2013 | 26 | 0.030 |
Why?
|
| Cytokines | 2 | 2014 | 2809 | 0.030 |
Why?
|
| Metribolone | 1 | 2013 | 48 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2013 | 6100 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 842 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 174 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2013 | 108 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2013 | 155 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2013 | 137 | 0.030 |
Why?
|
| Caspase 2 | 1 | 2012 | 39 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 3821 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 86 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2012 | 73 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2013 | 201 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2012 | 3890 | 0.030 |
Why?
|
| Esophagus | 2 | 2008 | 553 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 741 | 0.030 |
Why?
|
| Systems Biology | 1 | 2012 | 112 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 3578 | 0.030 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2011 | 10 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 89 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 143 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2008 | 1555 | 0.030 |
Why?
|
| Kenya | 1 | 2011 | 46 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 4744 | 0.030 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2011 | 42 | 0.030 |
Why?
|
| Germany | 1 | 2011 | 111 | 0.020 |
Why?
|
| Twist-Related Protein 1 | 1 | 2012 | 127 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 995 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1996 | 1234 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 155 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2014 | 436 | 0.020 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2013 | 259 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 236 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2008 | 1171 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 195 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 123 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2010 | 65 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2010 | 39 | 0.020 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 550 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 340 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 254 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 235 | 0.020 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2011 | 159 | 0.020 |
Why?
|
| Metagenome | 1 | 2011 | 176 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 1082 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 110 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 508 | 0.020 |
Why?
|
| Ethanol | 1 | 2012 | 264 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5319 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 442 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 421 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Gynecomastia | 1 | 2009 | 13 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 334 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Vacuoles | 1 | 2009 | 51 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 117 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2009 | 65 | 0.020 |
Why?
|
| Bacteria | 1 | 2014 | 611 | 0.020 |
Why?
|
| Plasmacytoma | 1 | 2010 | 111 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2009 | 79 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 64 | 0.020 |
Why?
|
| Stilbenes | 1 | 2009 | 86 | 0.020 |
Why?
|
| RNA Stability | 1 | 2009 | 125 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1165 | 0.020 |
Why?
|
| Tumor Protein p73 | 1 | 2008 | 105 | 0.020 |
Why?
|
| Founder Effect | 1 | 2008 | 42 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 611 | 0.020 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2008 | 38 | 0.020 |
Why?
|
| Rhodamine 123 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2008 | 38 | 0.020 |
Why?
|
| Adolescent | 4 | 2012 | 31252 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2008 | 61 | 0.020 |
Why?
|
| RNA Probes | 1 | 2008 | 44 | 0.020 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2008 | 5 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 7 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 1519 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 110 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2009 | 276 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 987 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 580 | 0.020 |
Why?
|
| G1 Phase | 1 | 2009 | 285 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 189 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2008 | 184 | 0.020 |
Why?
|
| WT1 Proteins | 1 | 2008 | 106 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 60 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 675 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2008 | 157 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2008 | 159 | 0.020 |
Why?
|
| Tyrosine | 1 | 2009 | 498 | 0.020 |
Why?
|
| Cyclin G | 1 | 2007 | 10 | 0.020 |
Why?
|
| Cyclin G1 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Albinism | 1 | 2007 | 17 | 0.020 |
Why?
|
| Fish Diseases | 1 | 2007 | 9 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2008 | 225 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 886 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 242 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 205 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 184 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 755 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 304 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 73 | 0.020 |
Why?
|
| Prostate | 1 | 2013 | 1088 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 1489 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 788 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2008 | 557 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 311 | 0.020 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2007 | 67 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 309 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 342 | 0.020 |
Why?
|
| DNA Damage | 2 | 2008 | 1954 | 0.020 |
Why?
|
| Erythroid Cells | 1 | 2007 | 49 | 0.020 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2007 | 84 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 2292 | 0.020 |
Why?
|
| Trisomy | 1 | 2008 | 231 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2006 | 159 | 0.020 |
Why?
|
| Retinal Degeneration | 1 | 2007 | 85 | 0.020 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2008 | 197 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 417 | 0.020 |
Why?
|
| Azacitidine | 1 | 2013 | 1149 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2008 | 515 | 0.020 |
Why?
|
| MafB Transcription Factor | 1 | 2006 | 12 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 2006 | 24 | 0.020 |
Why?
|
| Survival | 1 | 2006 | 177 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 483 | 0.020 |
Why?
|
| Quality Control | 1 | 2007 | 457 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 192 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 132 | 0.020 |
Why?
|
| Peptide Nucleic Acids | 1 | 2005 | 3 | 0.020 |
Why?
|
| CpG Islands | 1 | 2008 | 633 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 295 | 0.020 |
Why?
|
| Morpholinos | 1 | 2005 | 15 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 1022 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 406 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 810 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 844 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2007 | 400 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 545 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 461 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 760 | 0.020 |
Why?
|
| Camptothecin | 1 | 2008 | 517 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 173 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 694 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 3441 | 0.020 |
Why?
|
| Cytarabine | 1 | 2011 | 1973 | 0.020 |
Why?
|
| Sirolimus | 1 | 2009 | 814 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 671 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2009 | 1084 | 0.020 |
Why?
|
| Pyridines | 1 | 2012 | 1244 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 803 | 0.020 |
Why?
|
| Plasmids | 1 | 2006 | 837 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2005 | 120 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2005 | 164 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2007 | 397 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2006 | 347 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 2049 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 354 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 561 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 2063 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 494 | 0.010 |
Why?
|
| Barrett Esophagus | 1 | 2009 | 569 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 875 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 2307 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 13658 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 3033 | 0.010 |
Why?
|
| Eye | 1 | 2005 | 301 | 0.010 |
Why?
|
| Retina | 1 | 2007 | 532 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 905 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 630 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2006 | 749 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2008 | 32848 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 769 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 13310 | 0.010 |
Why?
|
| Binding Sites | 1 | 2007 | 2171 | 0.010 |
Why?
|
| Young Adult | 2 | 2012 | 21445 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2007 | 1459 | 0.010 |
Why?
|
| Texas | 1 | 2013 | 6311 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 783 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 212 | 0.010 |
Why?
|
| Photochemistry | 1 | 2001 | 39 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 208 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 1682 | 0.010 |
Why?
|
| Acrylic Resins | 1 | 2001 | 43 | 0.010 |
Why?
|
| Histidine | 1 | 2001 | 91 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 217 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2008 | 3005 | 0.010 |
Why?
|
| Pedigree | 1 | 2005 | 1890 | 0.010 |
Why?
|
| Duodenal Neoplasms | 1 | 2002 | 138 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 1544 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5112 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1879 | 0.010 |
Why?
|
| Proteomics | 1 | 2008 | 1380 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2006 | 1152 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 371 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 585 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 549 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 1960 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2007 | 1616 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12221 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 4988 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 1498 | 0.010 |
Why?
|
| Software | 1 | 2005 | 1321 | 0.010 |
Why?
|
| Pepstatins | 1 | 1997 | 1 | 0.010 |
Why?
|
| Mannosephosphates | 1 | 1997 | 5 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1997 | 29 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2007 | 2518 | 0.010 |
Why?
|
| Glycosylation | 1 | 1997 | 213 | 0.010 |
Why?
|
| Codon | 1 | 1997 | 241 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 2796 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 10001 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 6869 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 1129 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 5539 | 0.010 |
Why?
|
| Melanoma | 1 | 2011 | 5317 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 264 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 220 | 0.010 |
Why?
|
| Sex Factors | 1 | 1993 | 2139 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 15862 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 37905 | 0.000 |
Why?
|